The ‘Ethereal’ nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics-Reference-Cited by-同舟云学术

The ‘Ethereal’ nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics

Published:2008-10 Issue:20 Volume:18 Page:5350-5354
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Bazin Hélène G.,Murray Tim J.,Bowen William S.,Mozaffarian Afsaneh,Fling Steven P.,Bess Laura S.,Livesay Mark T.,Arnold Jeffrey S.,Johnson Craig L.,Ryter Kendal T.,Cluff Christopher W.,Evans Jay T.,Johnson David A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference33 articles.

1. Therapeutics targeting the innate immune system

2. Synthetic Vaccines: The Role of Adjuvants in Immune Targeting

3. Inhibition of Endotoxin Response by Synthetic TLR4 Antagonists

4. Molecular adjuvants and immunomodulators: new approaches to immunization

5. Cell activation by monosaccharide lipid A analogues utilizing Toll-like receptor 4

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 Agonists;Journal of Medicinal Chemistry;2023-10-17

2. Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 Vaccine;Pharmaceutics;2022-07-12

3. Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long Peptides;Journal of Medicinal Chemistry;2020-09-22

4. Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice;Frontiers in Immunology;2020-03-10

5. Co-encapsulation of synthetic lipidated TLR4 and TLR7/8 agonists in the liposomal bilayer results in a rapid, synergistic enhancement of vaccine-mediated humoral immunity;Journal of Controlled Release;2019-12